Friday, June 19, 2015 8:59:08 AM
I would think that any FOB partnership would be a step back for Momenta right now. Momenta has plenty of cash and future income that it doesn't need the few pennies a partner would give them.
If Momenta wants to really break out in the big league its best route would be to guide a FOB right through the FDA with the 'inter-changeable' label and then sell that drug to the highest bidder.
I can't see where they wouldn't be capable of doing this alone. What would the value of a interchangble Bio be? Billions.
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
